94 related articles for article (PubMed ID: 18172901)
1. Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer.
Uitterhoeve AL; Koolen MG; van Os RM; Koedooder K; van de Kar M; Pieters BR; Koning CC
Radiat Oncol; 2007 Jul; 2():27. PubMed ID: 17659094
[TBL] [Abstract][Full Text] [Related]
2. Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.
Ramroth J; Cutter DJ; Darby SC; Higgins GS; McGale P; Partridge M; Taylor CW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):736-747. PubMed ID: 27639294
[TBL] [Abstract][Full Text] [Related]
3. Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative.
Allen SG; Dragovic AF; Yin HM; Bryant AK; Paximadis PA; Matuszak MM; Schipper MJ; Dess RT; Hayman JA; Dominello MM; Kestin LL; Movsas B; Jolly S; Bergsma DP;
Pract Radiat Oncol; 2023; 13(5):444-453. PubMed ID: 37100388
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Toxicity of Moderately Hypofractionated Radiation Therapy with Helical TomoTherapy Versus Conventional Radiation Therapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicenter, Randomized Phase 3 Trial.
Zhang Q; Fan S; Xu X; Du S; Zhu G; Jiang C; Xia SA; Li Q; Wang Q; Qian D; Zhang M; Xiao H; Chen G; Zeng Z; He J
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38631536
[TBL] [Abstract][Full Text] [Related]
5. Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung Cancer.
Hui C; Marquez C; Lau B; Das M; Myall NJ; Roy M; Wakelee HA; Neal JW; Kovalchuk N; Chin A; Diehn M; Loo BW; Xiang M; Vitzthum LK
Clin Lung Cancer; 2024 Mar; 25(2):e92-e100.e4. PubMed ID: 38065707
[TBL] [Abstract][Full Text] [Related]
6. Effects of Radiotherapy and Chemotherapy on Platelet in Patients with Lung Cancer.
Tang S; Li L; Yuan S
Front Biosci (Landmark Ed); 2023 Nov; 28(11):310. PubMed ID: 38062815
[TBL] [Abstract][Full Text] [Related]
7. Lung Organotypic Slices Enable Rapid Quantification of Acute Radiotherapy Induced Toxicity.
Dubail M; Heinrich S; Portier L; Bastian J; Giuliano L; Aggar L; Berthault N; Londoño-Vallejo JA; Vilalta M; Boivin G; Sharma RA; Dutreix M; Fouillade C
Cells; 2023 Oct; 12(20):. PubMed ID: 37887279
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC).
Janssen S; Kaesmann L; Rudat V; Rades D
Lung; 2016 Apr; 194(2):291-4. PubMed ID: 26842723
[TBL] [Abstract][Full Text] [Related]
9. Cell division cycle 25 homolog c effects on low-dose hyper-radiosensitivity and induced radioresistance at elevated dosage in A549 cells.
Zhao Y; Cui Y; Han J; Ren J; Wu G; Cheng J
J Radiat Res; 2012 Sep; 53(5):686-94. PubMed ID: 22843362
[TBL] [Abstract][Full Text] [Related]
10. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase II study of amifostine mucosal protection by either subcutaneous injection or rapid IV bolus for patients with inoperable stage II-IIIA/B or stage IV non-small cell lung cancer with oligometastases receiving concurrent radiochemotherapy with carboplatin and paclitaxel followed by optional consolidative chemotherapy: a follow-up study after RTOG 98-01.
Werner-Wasik M; Langer C; Movsas B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):47-51. PubMed ID: 15726523
[TBL] [Abstract][Full Text] [Related]
12. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer.
Jeremić B; Milicić B
Cancer; 2008 Feb; 112(4):876-84. PubMed ID: 18172901
[TBL] [Abstract][Full Text] [Related]
13. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
Jeremić B; Milicić B; Acimović L; Milisavljević S
J Clin Oncol; 2005 Oct; 23(28):6873-80. PubMed ID: 16192579
[TBL] [Abstract][Full Text] [Related]
14. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: long-term results of a phase II study.
Jeremic B; Milicic B; Acimovic L; Milisavljevic S
J Clin Oncol; 2005 Feb; 23(6):1144-51. PubMed ID: 15718310
[TBL] [Abstract][Full Text] [Related]
15. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L
J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
